Trademark Overview
On Wednesday, July 9, 2025, a trademark application was filed for METIRRA with the United States Patent and Trademark Office. The USPTO has given the METIRRA trademark a serial number of 79432839. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 18, 2025. This trademark is owned by Envision Sciences Pty Ltd. The METIRRA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medicines; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances; biological preparations and substances for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; biotechnological preparations for medical use; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics; biosimilars; immunotherapeutic agents for cancer; biomarkers and antibod...
Diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; disease diagnosis services; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; healthcare consultancy services [medical services]; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; pathology services; oncology (medical services); services for the preparation of medical reports; information, advisory and consultancy services in relation to the aforementioned.
